Leiden, The Netherlands – September 15, 2025 – ProteoNic, a leader in premium vector technology for biologics and cell and gene therapy, today announced the launch of its novel 2G UNic® transposon ...
The lack of some genes in the BEC/TCEAL cluster could be related to some alterations associated with the autism spectrum disorder, according to a preclinical study published in the journal Genome ...
Transposon mutagenesis has emerged as a robust genome-wide approach for the identification of cancer driver genes. By harnessing the natural mobility of transposable elements, researchers can induce ...
Transposon mutagenesis identifies genes that cooperate with mutant Pten in breast cancer progression
Triple-negative breast cancer (TNBC) has the worst prognosis of any breast cancer subtype. To better understand the genetic forces driving TNBC, we performed a transposon mutagenesis screen in a ...
SAN DIEGO, March 04, 2026 (GLOBE NEWSWIRE) -- Transposon Therapeutics, a biotechnology company developing therapies for the treatment of neurodegenerative and aging-related diseases, today announced ...
We present here a Sleeping Beauty–based transposition system that offers a simple and efficient way to investigate the regulatory architecture of mammalian chromosomes in vivo. With this system, we ...
Research into the molecular mechanisms that lead to genomic instability within various organisms has led scientists to take a hard look at the tumor suppressor protein p53. As one of the most commonly ...
Substantial new evidence that health becomes endangered when aging cells lose control of rogue elements of DNA called transposons has been provided by recent research. A new study increases and ...
To exit the nucleus, ordinary RNA cargo must submit to rigorous quality control procedures. Transposon-silencing RNA, however, avoids all that. In fact, transposon-silencing RNA—PIWI-interacting RNA ...
NEWARK, Calif.--(BUSINESS WIRE)--ATUM (formerly DNA2.0 Inc.), a pioneer in bioengineering solutions, announce the issuance of patent No. 10,041,077 by the U.S. Patent and Trademark Office (USPTO) for ...
A new study provides substantial new evidence that health becomes endangered when aging cells lose control of rogue elements of DNA called transposons. A new study in the Proceedings of the National ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results